How is the diagnosis of Ataxia Neuropathy Spectrum confirmed?

Diagnosis combines clinical evaluation with genetic testing. First, a neurologist assesses ataxia, neuropathy, and any encephalopathy or ophthalmoplegia. Electrophysiological studies (nerve conduction, EMG) characterize the neuropathy. Brain MRI may show cerebellar atrophy. Definitive confirmation requires identifying pathogenic variants in the POLG gene (or rarely TWNK) via targeted sequencing or whole‑exome/genome testing.

Which factors can trigger seizures or worsen encephalopathy in these patients?

Seizures are often precipitated by metabolic stress, fever, certain medications (e.g., valproic acid, which is contraindicated), and rapid changes in glucose or electrolyte balance. Avoiding valproic acid, using low‑dose levetiracetam or clonazepam for seizure control, and treating infections promptly reduce risk. Additionally, prolonged fasting or high‑fat diets can exacerbate mitochondrial dysfunction, so maintain regular carbohydrate intake.

What is the inheritance pattern and how can families plan for future children?

taxia Neuropathy Spectrum is autosomal recessive. Both parents must carry one pathogenic POLG allele; each pregnancy carries a 25 % chance of an affected child, a 50 % chance of a carrier, and a 25 % chance of an unaffected non‑carrier. Carrier testing is available for parents and at‑risk relatives. For future pregnancies, options include preimplantation genetic testing (PGT‑M) with IVF, prenatal diagnostic testing (chorionic villus sampling or amniocentesis), or use of donor gametes. Genetic counseling is strongly recommended.

What therapies are available to manage the ataxia and peripheral neuropathy?

There is no disease‑modifying drug for POLG‑related disease, so care focuses on symptom control. Physical therapy and balance training help maintain coordination. Occupational therapy provides adaptive devices for fine‑motor tasks. For neuropathic pain, gabapentin, pregabalin, or duloxetine are commonly used. Vitamin B12 and folate supplementation are given if deficiencies are present, but they do not reverse the underlying defect.

Ataxia neuropathy spectrum

Ataxia neuropathy spectrum is a POLG‑related disorder that causes coordination problems, nerve dysfunction, and severe brain involvement, often with seizures and eye muscle weakness.

Overview

Ataxia neuropathy spectrum is part of a group of conditions called the POLG-related disorders. The conditions in this group feature a range of similar signs and symptoms involving muscle-, nerve-, and brain-related functions. Ataxia neuropathy spectrum now includes the conditions previously called mitochondrial recessive ataxia syndrome (MIRAS) and sensory ataxia neuropathy dysarthria and ophthalmoplegia (SANDO).

As the name implies, people with ataxia neuropathy spectrum typically have problems with coordination and balance (ataxia) and disturbances in nerve function (neuropathy). The neuropathy can be classified as sensory, motor, or a combination of the two (mixed). Sensory neuropathy causes numbness, tingling, or pain in the arms and legs, and motor neuropathy refers to disturbance in the nerves used for muscle movement.

Most people with ataxia neuropathy spectrum also have severe brain dysfunction (encephalopathy) and seizures. Some affected individuals have weakness of the external muscles of the eye (ophthalmoplegia), which leads to drooping eyelids (). Other signs and symptoms can include involuntary muscle twitches (myoclonus), liver disease, depression, migraine headaches, or blindness.

Symptoms

Ataxia (coordination and balance problems)
Neuropathy (sensory, motor, or mixed)
Encephalopathy (severe brain dysfunction)
Seizures
Ophthalmoplegia (weakness of eye muscles, drooping eyelids)
Myoclonus (involuntary muscle twitches)
Liver disease
Depression
Migraine headaches
Blindness

Causes & Risk Factors

Ataxia neuropathy spectrum is caused by mutations in the POLG gene or, rarely, the TWNK gene.

The POLG gene provides instructions for making one part, the alpha subunit, of a protein called polymerase gamma (pol γ). The TWNK gene provides instructions for making a protein called Twinkle. Pol γ and Twinkle function in , which are structures within cells that use oxygen to convert the energy from food into a form cells can use. Mitochondria each contain a small amount of DNA, known as (mtDNA), which is essential for the normal function of these structures. Pol γ and Twinkle are both integral to the process of by which new copies of mtDNA are produced.

Mutated pol γ or mutated Twinkle reduce mtDNA replication. Although the mechanisms are unknown, mutations in the POLG gene often result in fewer copies of mtDNA (mtDNA depletion), and mutations in the TWNK gene often result in deletions of large regions of mtDNA (mtDNA deletion). MtDNA depletion or deletion occurs most commonly in muscle, brain, or liver cells. MtDNA depletion causes a decrease in cellular energy, which could account for the signs and symptoms of ataxia neuropathy spectrum. It is unclear what role mtDNA deletions play in the signs and symptoms of the condition.

Genes Associated with Ataxia Neuropathy Spectrum

POLG
TWNK

Genetics

Ataxia neuropathy spectrum can have different inheritance patterns depending on the associated gene.

Mutations in the POLG gene cause a form of the condition that is inherited in an , which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Mutations in the TWNK gene cause a form of the condition that is inherited in an , which means one copy of the altered gene in each cell is sufficient to cause the disorder.

Other Names for This Condition

ANS
MIRAS
Mitochondrial recessive ataxia syndrome
SANDO
Sensory ataxia neuropathy dysarthria and ophthalmoplegia

Resources

Genetic Testing Information

Genetic Testing Registry: Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis

Genetic and Rare Diseases Information Center

Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome

Patient Support and Advocacy Resources

National Organization for Rare Disorders (NORD)

Clinical Trials

ClinicalTrials.gov

Catalog of Genes and Diseases from OMIM

SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO

Scientific Articles on PubMed

PubMed

References

Chan SS, Longley MJ, Copeland WC. The common A467T mutation in the human mitochondrial DNA polymerase (POLG) compromises catalytic efficiency and interaction with the accessory subunit. J Biol Chem. 2005 Sep 9;280(36):31341-6. doi: 10.1074/jbc.M506762200. Epub 2005 Jul 16. Citation on PubMed
Cohen BH, Chinnery PF, Copeland WC. POLG-Related Disorders. 2010 Mar 16 [updated 2024 Feb 29]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK26471/ Citation on PubMed
Hudson G, Deschauer M, Busse K, Zierz S, Chinnery PF. Sensory ataxic neuropathy due to a novel C10Orf2 mutation with probable germline mosaicism. Neurology. 2005 Jan 25;64(2):371-3. doi: 10.1212/01.WNL.0000149767.51152.83. Citation on PubMed
Milone M, Massie R. Polymerase gamma 1 mutations: clinical correlations. Neurologist. 2010 Mar;16(2):84-91. doi: 10.1097/NRL.0b013e3181c78a89. Citation on PubMed
Moraes CT, Shanske S, Tritschler HJ, Aprille JR, Andreetta F, Bonilla E, Schon EA, DiMauro S. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet. 1991 Mar;48(3):492-501. Citation on PubMed or Free article on PubMed Central
Rocher C, Taanman JW, Pierron D, Faustin B, Benard G, Rossignol R, Malgat M, Pedespan L, Letellier T. Influence of mitochondrial DNA level on cellular energy metabolism: implications for mitochondrial diseases. J Bioenerg Biomembr. 2008 Apr;40(2):59-67. doi: 10.1007/s10863-008-9130-5. Epub 2008 Apr 16. Citation on PubMed
Stumpf JD, Copeland WC. Mitochondrial DNA replication and disease: insights from DNA polymerase gamma mutations. Cell Mol Life Sci. 2011 Jan;68(2):219-33. doi: 10.1007/s00018-010-0530-4. Epub 2010 Oct 8. Citation on PubMed or Free article on PubMed Central
Van Goethem G, Martin JJ, Dermaut B, Lofgren A, Wibail A, Ververken D, Tack P, Dehaene I, Van Zandijcke M, Moonen M, Ceuterick C, De Jonghe P, Van Broeckhoven C. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord. 2003 Feb;13(2):133-42. doi: 10.1016/s0960-8966(02)00216-x. Citation on PubMed

Medical Encyclopedia

Genetics

Understanding Genetics

What is